九州大学病院は、福岡市東区にある九州大学医学部・歯学部附属の大学病院である。大分県別府市には分院の九州大学病院別府病院がある。2014年の患者数は、医科外来521,830名、歯科外来168,992名、医科入院396,823名、歯科入院12,957名である。略称は九大病院。

During the past decade, Kyushu University Hospital conducted 144 clinical trials. In the 10-year time frame, 144 clinical trials started and 51 clinical trials were completed, i.e. on average, 35.4% percent of trials that started reached the finish line to date. In the past 5 years, 62 clinical trials started and 34 clinical trials were completed. i.e. 54.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kyushu University Hospital" #1 sponsor was "Hoffmann-La Roche" with 15 trials, followed by "Pfizer" with 15 trials sponsored, "Takeda" with 12 trials sponsored, "Celgene" with 10 trials sponsored and "Incyte Corporation" with 10 trials sponsored. Other sponsors include 129 different institutions and companies that sponsored additional 69 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kyushu University Hospital" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 9 trials as a collaborator, "Japan Agency for Medical Research and Development" with 6 trials as a collaborator, "Merck Sharp & Dohme LLC" with 5 trials as a collaborator, "ADIR, a Servier Group company" with 3 trials as a collaborator and "AstraZeneca" with 3 trials as a collaborator. Other collaborators include 71 different institutions and companies that were collaborators in the rest 69 trials.

According to Clinical.Site data, the most researched conditions in "Kyushu University Hospital" are "Multiple Myeloma" (7 trials), "Heart Failure" (5 trials), "Non-Small Cell Lung Cancer" (5 trials), "Acute Myeloid Leukemia" (4 trials) and "Carcinoma, Renal Cell" (4 trials). Many other conditions were trialed in "Kyushu University Hospital" in a lesser frequency.

Most popular intervention types in "Kyushu University Hospital" are "Drug" (160 trials), "Biological" (25 trials), "Other" (16 trials), "Device" (9 trials) and "Procedure" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (35 trials), "Atezolizumab" (10 trials), "Pembrolizumab" (9 trials), "Dexamethasone" (7 trials) and "Docetaxel" (7 trials). Other intervention names were less common.

The vast majority of trials in "Kyushu University Hospital" are 183 trials for "All" genders, 7 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Kyushu University Hospital". undefined are not yet recruiting, 47 are recruiting, 50 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 84 completed trials in Kyushu University Hospital, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Kyushu University Hospital, 29 "Phase 1" clinical trials were conducted, 47 "Phase 2" clinical trials and 111 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 6 trials that are defined as “Not Applicable".